Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
29.25    0.00 (0.00%)
Bid:
28.50
Ask:
30.00
Spread: 1.50 (5.263%)
Market Cap: £123.70m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Trading Update

1 May 2008 07:01

Merchant Securities PLC01 May 2008 1 May 2008 Merchant Securities plc ("Merchant Securities" or the "Company") Trading update The Board of Merchant Securities, the financial services company specialising inprivate client and institutional stockbroking, corporate finance services andprivate equity, announces a trading update for the year ended 31March 2008. As stated at the time of the Company's interim announcement in December 2007,the Company continues to make progress in developing its core activities and instrengthening the infrastructure of its business. In this regard, the Companyhas achieved the following strategic developments in the second half of itsfinancial year: • Merchant Securities Group Limited, ("MSGL") its stockbroking subsidiary, became a member of the London Stock Exchange in February 2008; • A new, upgraded private client investment management system and a transfer of the settlement and clearing functions to Pershing in February 2008; • Its management team has been strengthened by the appointment of a new Chief Financial Officer and a new Compliance Officer; • In October 2007, it completed the acquisition of John East & Partners, a corporate finance adviser, nominated adviser and corporate broker, which made a positive contribution to the group, post acquisition, in the year ended 31 March 2008; • It has recruited a senior institutional research and sales team which is due to join MSGL within the next two months. As a result of these developments, a number of costs have been incurred. Inaddition, market conditions have deteriorated since the announcement of theCompany's interim results and a number of the larger private equity transactionsin progress at that time have not been completed as originally anticipated.Consequently, the Company expects that it will have incurred a loss aftertaxation in the region of £600,000, after taking account of non-recurring itemsof approximately £400,000, in the financial year ended 31 March 2008. The board continues to pursue its strategy of building a diversified financialservices group and some non-recurring reorganisation costs are an inevitableconsequence. The board remains confident that the successful implementation ofits strategy will see significant benefits accruing to the Company in the mediumterm. The Company expects to announce it results for the year ended 31 March 2008 inthe second half of July 2008. ENDS For further information please contact: Anthony Fabrizi Chief Executive 020 7375 9060 Merchant Securities Roland Cross Director 020 7726 6111 Broadgate Richard Day Director 020 7398 1600 Arden Partners plc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.